Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Genetic and functional evaluation of MITF as a candidate gene for cutaneous melanoma predisposition in pigs.

Bourneuf E, Du ZQ, Estellé J, Gilbert H, Créchet F, Piton G, Milan D, Geffrotin C, Lathrop M, Demenais F, Rogel-Gaillard C, Vincent-Naulleau S.

Mamm Genome. 2011 Oct;22(9-10):602-12. doi: 10.1007/s00335-011-9334-6. Epub 2011 May 28.

PMID:
21626174
2.

Detection of novel quantitative trait loci for cutaneous melanoma by genome-wide scan in the MeLiM swine model.

Du ZQ, Vincent-Naulleau S, Gilbert H, Vignoles F, Créchet F, Shimogiri T, Yasue H, Leplat JJ, Bouet S, Gruand J, Horak V, Milan D, Le Roy P, Geffrotin C.

Int J Cancer. 2007 Jan 15;120(2):303-20.

3.

KIT and melanoma predisposition in pigs: sequence variants and association analysis.

Fernández-Rodríguez A, Estellé J, Blin A, Muñoz M, Créchet F, Demenais F, Vincent-Naulleau S, Bourneuf E.

Anim Genet. 2014 Jun;45(3):445-8. doi: 10.1111/age.12136. Epub 2014 Mar 15.

PMID:
24628300
4.

PGC-1 coactivators regulate MITF and the tanning response.

Shoag J, Haq R, Zhang M, Liu L, Rowe GC, Jiang A, Koulisis N, Farrel C, Amos CI, Wei Q, Lee JE, Zhang J, Kupper TS, Qureshi AA, Cui R, Han J, Fisher DE, Arany Z.

Mol Cell. 2013 Jan 10;49(1):145-57. doi: 10.1016/j.molcel.2012.10.027. Epub 2012 Nov 29.

5.

A germline oncogenic MITF mutation and tumor susceptibility.

Paillerets BB, Lesueur F, Bertolotto C.

Eur J Cell Biol. 2014 Jan-Feb;93(1-2):71-5. doi: 10.1016/j.ejcb.2013.10.002. Epub 2013 Oct 26. Review.

PMID:
24290354
6.

Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.

Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B.

Neoplasia. 2014 Jun;16(6):529-42. doi: 10.1016/j.neo.2014.06.001. Epub 2014 Jul 13.

7.

ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.

Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD.

Pigment Cell Melanoma Res. 2010 Feb;23(1):93-102. doi: 10.1111/j.1755-148X.2009.00652.x. Epub 2009 Nov 6.

PMID:
19895547
8.

A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.

Lister JA, Capper A, Zeng Z, Mathers ME, Richardson J, Paranthaman K, Jackson IJ, Elizabeth Patton E.

J Invest Dermatol. 2014 Jan;134(1):133-140. doi: 10.1038/jid.2013.293. Epub 2013 Jul 5.

9.

Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma.

Zhiqi S, Soltani MH, Bhat KM, Sangha N, Fang D, Hunter JJ, Setaluri V.

Melanoma Res. 2004 Dec;14(6):509-16.

PMID:
15577322
10.
11.

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.

Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Bertolotto C.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw340.

PMID:
28376192
12.

A de novo silencer causes elimination of MITF-M expression and profound hearing loss in pigs.

Chen L, Guo W, Ren L, Yang M, Zhao Y, Guo Z, Yi H, Li M, Hu Y, Long X, Sun B, Li J, Zhai S, Zhang T, Tian S, Meng Q, Yu N, Zhu D, Tang G, Tang Q, Ren L, Liu K, Zhang S, Che T, Yu Z, Wu N, Jing L, Zhang R, Cong T, Chen S, Zhao Y, Zhang Y, Bai X, Guo Y, Zhao L, Zhang F, Zhao H, Zhang L, Hou Z, Zhao J, Li J, Zhang L, Sun W, Zou X, Wang T, Ge L, Liu Z, Hu X, Wang J, Yang S, Li N.

BMC Biol. 2016 Jun 27;14:52. doi: 10.1186/s12915-016-0273-2.

13.

Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.

Katoh I, Mírová A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, Sakai T, Hashimoto K, Maruyama A, Yonaga T, Fukunishi N, Moriishi K, Hirai H.

Neoplasia. 2011 Nov;13(11):1081-92.

14.
15.

Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.

Hertzman Johansson C, Azimi A, Frostvik Stolt M, Shojaee S, Wiberg H, Grafström E, Hansson J, Egyházi Brage S.

Melanoma Res. 2013 Oct;23(5):360-5. doi: 10.1097/CMR.0b013e328362f9cd.

PMID:
23921446
16.

Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation.

Egidy G, Julé S, Bossé P, Bernex F, Geffrotin C, Vincent-Naulleau S, Horak V, Sastre-Garau X, Panthier JJ.

Mol Cancer. 2008 Apr 28;7:34. doi: 10.1186/1476-4598-7-34.

17.

A role for ATF2 in regulating MITF and melanoma development.

Shah M, Bhoumik A, Goel V, Dewing A, Breitwieser W, Kluger H, Krajewski S, Krajewska M, Dehart J, Lau E, Kallenberg DM, Jeong H, Eroshkin A, Bennett DC, Chin L, Bosenberg M, Jones N, Ronai ZA.

PLoS Genet. 2010 Dec 23;6(12):e1001258. doi: 10.1371/journal.pgen.1001258.

18.

MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein.

Goswami S, Tarapore RS, Teslaa JJ, Grinblat Y, Setaluri V, Spiegelman VS.

J Biol Chem. 2010 Jul 2;285(27):20532-40. doi: 10.1074/jbc.M110.109298. Epub 2010 May 3. Retraction in: J Biol Chem. 2014 Apr 25;289(17):11859.

19.

MITF pathway mutations in melanoma.

Yokoyama S, Salma N, Fisher DE.

Pigment Cell Melanoma Res. 2009 Aug;22(4):376-7. doi: 10.1111/j.1755-148X.2009.00599.x. Epub 2009 Jun 25. No abstract available.

PMID:
19558635
20.

Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model.

Geffrotin C, Crechet F, Le Roy P, Le Chalony C, Leplat JJ, Iannuccelli N, Barbosa A, Renard C, Gruand J, Milan D, Horak V, Tricaud Y, Bouet S, Franck M, Frelat G, Vincent-Naulleau S.

Int J Cancer. 2004 May 20;110(1):39-50.

Supplemental Content

Support Center